BOYDSense
Toulouse, France
BOYDSense is developing a non-invasive health monitoring platform, starting with Diabetes. Our device named Lassie, like the dog of the series in the 80s, measures volatile organic compound (VOCs) biomarkers in exhaled breath. Lassie will make it easier and painless for people with diabetes to monitor their blood glucose all through the day by simply breathing. The device will be affordable, gentle and non-invasive. Our latest performance data from interim data analysis are showing scientifically proven results.
Company Info
- Founded
- 2019
- Website
- www.boydsense.com/
Categories
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of BOYDSense?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.